Back to Market Feed

XIIDRA 5% EYE DROPS

Lifitegrast
$11.8386per EA

Strength

50 mg/mL

NDC

24208091112

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

1/1/2026

Active Ingredients

LIFITEGRAST

Approval Type

New Drug (NDA)

FDA Application

NDA208073

On Market Since

1/2/2024

Pharmacological Classes

Lymphocyte Function-Associated Antigen-1 Antagonist
Lymphocyte Function-Associated Antigen-1 Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+5.4%

3Y

N/A

5Y

N/A

All

+5.4%

Generic Alternatives

1 alternative • Same active ingredient

XIIDRA 5% EYE DROPS
Brand
00078091112•Novartis Pharmaceuticals Corporation
$11.8386

Related Drugs

Same classification

No related drugs found.